Neonatal bone marrow transplantation (BMT) could offer a novel therapeutic opportunity for genetic disorders by providing sustainable levels of the missing protein at birth, thus preventing tissue damage. We tested this concept inmucopolysaccharidosis type I (MPS IH; Hurler syndrome), a lysosomal storage disorder caused by deficiency of a-L-iduronidase. MPS IH is characterized by a broad spectrum of clinicalmanifestations, including severe progressive skeletal abnormalities. AlthoughBMTincreases the life spanofpatientswithMPSIH, musculoskeletal manifestations are only minimally responsive if the timing of BMT delays, suggesting already irreversible bonedamage. In this study,wetested the hypothesis that transplanting normal BM into newborn MPS I mice soon after birth can prevent skeletal dysplasia. We observed that neonatal BMT was effective at restoring α-L-iduronidase activity and clearing elevated glycosaminoglycans in blood and multiple organs. At 37 weeks of age,weobserved an almost complete normalization of all bone tissue parameters, using radiographic, microcomputed tomography, biochemical, and histological analyses. Overall, the magnitude of improvements correlated with the extent of hematopoietic engraftment. Weconclude that BMT at a very early stage in lifemarkedly reduces signs and symptoms of MPS I before they appear.

Pievani, A., Azario, I., Antolini, L., Shimada, T., Patel, P., Remoli, C., et al. (2015). Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I. BLOOD, 125(10), 1662-1671 [10.1182/blood-2014-06-581207].

Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I

PIEVANI, ALICE SILVIA
Primo
;
AZARIO, ISABELLA MARIA REBECCA;ANTOLINI, LAURA;Rambaldi, B;VALSECCHI, MARIA GRAZIA;BIONDI, ANDREA;Serafini, M.
2015

Abstract

Neonatal bone marrow transplantation (BMT) could offer a novel therapeutic opportunity for genetic disorders by providing sustainable levels of the missing protein at birth, thus preventing tissue damage. We tested this concept inmucopolysaccharidosis type I (MPS IH; Hurler syndrome), a lysosomal storage disorder caused by deficiency of a-L-iduronidase. MPS IH is characterized by a broad spectrum of clinicalmanifestations, including severe progressive skeletal abnormalities. AlthoughBMTincreases the life spanofpatientswithMPSIH, musculoskeletal manifestations are only minimally responsive if the timing of BMT delays, suggesting already irreversible bonedamage. In this study,wetested the hypothesis that transplanting normal BM into newborn MPS I mice soon after birth can prevent skeletal dysplasia. We observed that neonatal BMT was effective at restoring α-L-iduronidase activity and clearing elevated glycosaminoglycans in blood and multiple organs. At 37 weeks of age,weobserved an almost complete normalization of all bone tissue parameters, using radiographic, microcomputed tomography, biochemical, and histological analyses. Overall, the magnitude of improvements correlated with the extent of hematopoietic engraftment. Weconclude that BMT at a very early stage in lifemarkedly reduces signs and symptoms of MPS I before they appear.
Articolo in rivista - Articolo scientifico
Hurler syndrome, bone marrow transplantation, bone
English
2015
125
10
1662
1671
reserved
Pievani, A., Azario, I., Antolini, L., Shimada, T., Patel, P., Remoli, C., et al. (2015). Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I. BLOOD, 125(10), 1662-1671 [10.1182/blood-2014-06-581207].
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0006497120352010-main.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 1.64 MB
Formato Adobe PDF
1.64 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/66988
Citazioni
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 30
Social impact